Form 8-K - Current report:
SEC Accession No. 0001125345-24-000165
Filing Date
2024-11-21
Accepted
2024-11-21 16:32:11
Documents
13
Period of Report
2024-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20241118.htm   iXBRL 8-K 27512
  Complete submission text file 0001125345-24-000165.txt   150189

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20241118.xsd EX-101.SCH 1782
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20241118_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20241118_pre.xml EX-101.PRE 12508
15 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20241118_htm.xml XML 2717
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 241484917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)